Introduction
Lung cancer is one of the most common cancers and is the leading cause of cancerrelated deaths worldwide. There were 1.8 million new diagnoses of lung cancer in 2012, accounting for 13% of the global cancer burden. 1 The incidence and mortality rates of lung cancer in China were estimated to be 0.7 and 0.6 million cases in 2015. 2 Although smoking is the key risk factor for lung cancer, there are lung cancer patients without a smoking history. 3 An increasing number of studies have proven that genetic factors play a key role in the development of nonsmall cell lung cancer (NSCLC), which accounts for approximately 80% of lung cancer cases.
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Li et al MicroRNAs (miRNAs) are a group of short RNAs with 20-23 noncoding nucleotides that play important modulatory roles in various biological processes through posttranscriptional regulation. It is estimated that miRNAs regulate more than 30% of all human genes 4, 5 and are involved in crucial physiological processes, such as proliferation, apoptosis, differentiation, tumorigenesis, and cancer metastasis. [5] [6] [7] [8] Recently, studies have indicated the aberrant expression of miRNAs in human cancers, [9] [10] [11] including lung cancer. 12 Moreover, Sheervalilou et al 13 showed that aberrant expression of miRNAs in lung cancer might induce lung tumorigenesis. On the other hand, functional studies have shown that single nucleotide polymorphisms (SNPs) in miRNA genes may be associated with miRNA expression 14, 15 and target gene expression. 16 Moreover, several studies have shown that SNPs in miRNA are associated with human cancers, [17] [18] [19] [20] [21] for example, in 2014, Wang et al reported that rs3746444 in miR-499a and rs11614913 in miR-196a2 were associated with lung cancer. 22 In the current study, we evaluated the association of SNPs (rs11134527 in pri-miR-218-2; rs74693964 in pri-miR-145; rs6062251 in pri-miR-133a-2; rs4705343 in pri-miR-143) in miRNA genes with NSCLC in a Han Chinese population. Our results revealed the role of genetic variations in the miRNA genes in the development of NSCLC in a Han Chinese population. 23 The pathologic stage was determined according to the International System for Staging Lung Cancer. 24 Based on the pathomorphological reports, the NSCLC cases included adenocarcinoma (AC), squamous cell carcinoma (SCC), and both AC and SCC. NSCLC patients with a prior history of primary cancer other than lung cancer were excluded from the current study. Clinical characteristics and data, such 
Materials and methods
Ethics statement
SNP genotyping
Genomic DNA was extracted from peripheral lymphocytes using the QIAamp Blood Mini Kit (Qiagen, Hilden, Germany). Four SNPs in miRNA genes, namely, rs11134527, rs74693964, rs6062251, and rs4705343, were genotyped using PCR amplification with a TaqMan assay. Primers and probes were purchased from Applied Biosystems (Foster City, CA, USA). To identify the accuracy of SNP genotyping by the TaqMan assay, three positive controls and one negative control were genotyped via TaqMan assay at the same time.
Statistical analysis SPSS 19.0 (IBM Corporation, Armonk, NY, USA) and Microsoft Excel were used to conduct the statistical analyses. The Student's t-test or one-way analysis of variance was used to test the quantitative variables, and the categorical data were compared by chi-square test. The allelic and genotypic frequencies of the four SNPs were calculated by the direct counting method. Hardy-Weinberg equilibrium (HWE) was tested for the SNPs in both the NSCLC and control groups. The genetic association between the SNPs in miRNA genes and NSCLC susceptibility was calculated using a binary logistic regression with gender and age as the covariates, and the ORs with the associated 95% CIs of allele-specific risks were also calculated. In addition, the Hosmer-Lemeshow test and the Nagelkerke R 2 were employed to establish the optimal model. The association between genotypes of the SNPs and NSCLC was analyzed using the inheritance model analysis of SNPStats software. 25 Five models including the codominant, dominant, recessive, overdominant, and log-additive were analyzed. The best-fit inheritance model was determined using the Akaike information criterion and Bayesian information criterion, which possesses the minimal Akaike information criterion and Bayesian information criterion values. A P value less than 0.05 was considered statistically significant. 
Results
Subject characteristics
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Association between miRNA polymorphisms and nonsmall cell lung cancer control groups (P>0.05). In the NSCLC individuals, 271 had AC, 169 had SCC, and 12 had both AC and SCC. There were 70 patients in pathological stage I, 77 in stage II, 161 in stage III, and 144 in stage IV.
Association of the four SNPs with NSCLC
The allelic and genotypic frequencies of the four SNPs in the miRNAs are displayed in Table 2 . Genotypic frequencies of the four SNPs were in HWE for the case and control groups (P>0.05). The allelic and genotypic frequencies of rs11134527 were significantly different in the NSCLC and control groups (P=0.025 and 0.045, respectively). The A allele of rs11134527 occurred more frequently in the NSCLC group compared with the control group (OR=1.24; 95% CI: 1.03-1.50). The allelic frequencies for rs4705343 were significantly different between the NSCLC and control groups (P=0.029). The frequency of the A allele for rs4705343 was significantly higher in the control group than that in the NSCLC group (OR=0.80; 95% CI: 0.66-0.98). The allelic and genotypic frequencies of rs74693964 and rs6062251 showed no significant difference between the NSCLC and control groups (P>0.05). Tables 3-6 present the results of the analyses of the different inheritance model for the four SNPs. The genotypic frequency of rs11134527 A/G+G/G was significantly different from A/A (P=0.011) under the dominant model between the NSCLC and control groups. The A/G+GG genotype was associated with a decreased risk of NSCLC (OR=0.69; 95% CI: 0.52-0.92). The genotypic frequencies of rs4705343 were significantly different under the log-additive model between the NSCLC and control groups (P=0.036). The 2CC+T/C genotype was associated with a higher risk of NSCLC (OR=1.25; 95% CI: 1.01-1.53).
Model of inheritance analysis of the four SNPs with NSCLC
Association analysis of the four SNPs with different pathologic stages Table 7 shows the results of the association analysis of the four SNPs between pathologic stages I+II and III+IV. There were no significant differences in the allelic and genotypic frequencies for the four SNPs between pathologic stages I+II and III+IV (P>0.05).
Association analysis of the four SNPs with AC and SCC
Our results showed that the allelic and genotypic frequencies of rs11134527 were significantly different between AC and SCC (P=0.005 and 0.015, respectively). The A allele was associated with SCC (OR=0.65; 95% CI: 0.48-0.88) ( Table 8) . 
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Discussion
Recently, many studies have reported the association of miRNA genes and NSCLC. In addition, several studies have been carried out to evaluate the association of SNPs located in miRNA genes with the susceptibility of cancers, including NSCLC. In the current study, we analyzed the association of four SNPs (rs11134527 in pri-miR-218-2; rs74693964 in pri-miR-145; rs6062251 in pri-miR-133a-2; rs4705343 in pri-miR-143) in miRNAs with NSCLC susceptibility in a Han Chinese population. Our results showed that the A allele of rs11134527 might be a risk factor and that the T allele of rs4705343 might be a protective factor for NSCLC in this Han Chinese population. miR-218 has been reported to be downregulated in various cancers. [26] [27] [28] In 2010, Wu et al 29 reported that reduced expression of miR-218 was associated with worse survival in lung cancer. Then, Kumamoto et al 30 found that ectopic expression of miR-218 significantly inhibited cancer cell migration and invasion in lung cancer. In addition, some studies have found associations between rs11134527, located at pri-miR-218-2, and the risk of different human cancers, such as esophageal squamous cell carcinoma (ESCC), 
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Association between miRNA polymorphisms and nonsmall cell lung cancer cervical cancer, 32, 33 and hepatocellular carcinoma. Our results also showed that the genotypic and allelic frequencies of rs11134527 were significantly different between the NSCLC and control groups. Allele A of rs11134527 was associated with a higher risk of NSCLC. Our results are consistent with previous studies performed on cervical cancer that found that the rs11134527 GG genotype was associated with a decreased risk of cervical carcinoma 32, 33 and ESCC, 31 which indicated that rs11134527 might alter the expression of miR-218 and be associated with cancer. However, Zhang et al 34 and Zhang et al 35 found that there was no association of this SNP with ESCC and hepatocellular carcinoma, respectively. The reason for these different results might be the different cancer types. 
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Li et al miR-143, a tumor suppressor of various types of human cancer, has been demonstrated to play crucial roles in tumor growth, migration, and invasion. [36] [37] [38] In lung cancer, miR-143 can inhibit the genesis and development of tumors through directly suppressing the expression of its target genes. 39, 40 Recently, an integrated bioinformatics analysis showed that miR-143 was downregulated in NSCLC. 41 These data indicate that miR-143 is important for the initiation and development of human cancers. Based on this, other studies have investigated the association of SNPs in miR-143 with human cancers and found that SNPs (such as rs4705343 and rs353292) in miR-143 are associated with several cancers. [42] [43] [44] In the current study, we found that allele T of rs4705343 was associated with a decreased risk of NSCLC, which is in agreement with the results of a case-control study on cervical SCC. 45 These results also indicate that rs4705343 in miR-143 plays an important role in NSCLC and cervical SCC.
Downregulation of miR-145 and miR-133a has been reported in cancers. Several SNPs located in the flanking region of the miR-145 gene were demonstrated to be associated with the expression of miR-145 and disease susceptibility. 43, [45] [46] [47] In 2016, Xiao et al 48 identified miR-133 as a biomarker for lung cancer. In addition, several studies have found an association between SNPs in the miR-133 gene (rs8089787, rs9948906, rs13040413, and rs200375711) with different diseases. 49, 50 In the current study, we analyzed the association of rs74693964 in miR-145 and rs6062251 in miR-133a2 with NSCLC. However, we did not find an association of rs74693964 in pri-miR-145 or rs6062251 in pri-miR-133a-2 with NSCLC in the current population.
A limitation of the present study is that we did not ascertain the smoking status of the control individuals, making it difficult to perform future analyses of such exposure variables or a gene-smoking interaction analysis. This limitation may neutralize the effect of smoking and expose the effects of genetic variants in our study.
Conclusion
In the current study, we investigated the association of four SNPs located in four tumor suppressor miRNA genes ( pri-miR-218-2, pri-miR-143, pri-miR-145 , and pri-miR133a-2) with NSCLC in a Chinese Han population. Our results showed that the A allele of rs11134527 in primiR-218-2 might be a risk factor for lung cancer. In addition, the T allele of rs4705343 in pri-miR-143 might be associated with a decreased risk of NSCLC. Our findings provide evidence that rs11134527 in pri-miR-218-2 and rs4705343 in pri-miR-143 may be new biomarkers for NSCLC. However, we analyzed the distribution of the SNPs between Asian and European populations (http://asia.ensembl.org/Homo_sapi-ens/Info/Index) and found that the allelic frequencies selected in the current study were significantly different between these two populations ( Table 9 ). This result might suggest that it is necessary to evaluate the association of these SNPs with NSCLC in different populations before these SNPs are used as new biomarkers for NSCLC. 
